Forward Water Technologies Announces Financial Results for the Three-Months and Nine-Months Ended December 31, 2025
TSX-V: FWTC98
Financial Highlights
For the three-month and nine-month periods ended
|
|
Three Months Ended |
Nine Months Ended |
|
Revenue |
|
|
|
Net Loss/Comprehensive Loss |
|
|
|
Loss Per Share |
|
|
|
Total Assets |
n/a |
|
|
Cash at End of Period |
n/a |
|
Operating Highlights and Recent Corporate Developments
- On
October 29, 2025 , FWTC issued 1,025 convertible debenture units in an aggregate principal amount of$1,025,000 . Each unit consists of$1,000 principal amount of convertible debentures and 5,000 common share purchase warrants. Each warrant entitles the holder to purchase a common share of the Company untilOctober 29, 2028 . The exercise price of the warrants is$0.07 per common share if exercised on or beforeOctober 29, 2026 and$0.10 thereafter until expiry. The convertible debentures mature onOctober 29, 2028 and bear interest at 14% per annum, payable annually on the last business day of each year. The holders have the option to convert the principal owing into common shares of the Company at a conversion price of$0.07 per share on or beforeOctober 29, 2026 and$0.10 per share thereafter until maturity or repayment. - On
November 18, 2025 , FWTC signed a contract for a technology evaluation project with a globally positioned food and beverage product manufacturer. The project will assess the effectiveness of FWTC's treatment technology for concentrating liquid food and beverage streams to create superior quality concentrates.
Management Commentary
In the last quarter, FWTC has attracted additional interest from major companies by leveraging previous successes. CEO
Summary of Financial Results
Income Statement
|
|
|
For the three months ended |
For the nine months ended |
||
|
|
|
2025 |
2024 |
2025 |
2024 |
|
|
|
|
|
|
|
|
Revenue |
|
$ 54,356 |
$ 56,881 |
$ 59,048 |
$ 56,881 |
|
|
|
|
|
|
|
|
Expenses: |
|
|
|
|
|
|
General and administrative |
|
229,002 |
579,893 |
745,824 |
771,509 |
|
Selling and marketing |
|
10,323 |
21,166 |
10,335 |
21,166 |
|
Research and development |
|
211,150 |
130,842 |
609,494 |
130,842 |
|
Listing expenses |
|
- |
- |
- |
22,775 |
|
Foreign exchange loss (income) |
|
(15,196) |
30,287 |
(19,888) |
30,287 |
|
|
|
435,279 |
762,188 |
1,345,765 |
976,579 |
|
|
|
|
|
|
|
|
Net loss before the undernoted |
|
(380,923) |
(705,307) |
(1,286,717) |
(919,698) |
|
|
|
|
|
|
|
|
Other expense (income): |
|
|
|
|
|
|
Amortization of deferred capital contributions |
|
(1,056) |
(1,056) |
(3,168) |
(1,056) |
|
Finance income |
|
(203) |
(295) |
(220) |
(31,189) |
|
Finance costs |
|
51,712 |
18,501 |
77,932 |
9,108 |
|
|
|
50,453 |
17,150 |
74,544 |
(23,137) |
|
|
|
|
|
|
|
|
Net loss and comprehensive loss |
|
$ (431,376) |
$ (722,457) |
$ (1,361,261) |
$ (896,561) |
|
|
|
|
|
|
|
|
Loss and comprehensive loss per share |
|
|
|
|
|
|
Basic and diluted |
|
(0.009) |
(0.015) |
(0.027) |
(0.018) |
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding |
|
|
|
|
|
|
Basic and diluted |
|
49,924,939 |
49,174,592 |
49,833,836 |
49,174,592 |
Balance Sheet
|
|
|
|
|
|
2025 |
2025 |
|
Assets |
|
|
|
|
|
|
|
Total current assets |
703,630 |
771,415 |
|
Property and equipment |
1,350,770 |
1,577,896 |
|
Intangible assets |
985,715 |
1,114,286 |
|
|
280,968 |
280,968 |
|
|
$ 3,321,083 |
$ 3,744,565 |
|
|
|
|
|
Liabilities and Shareholders' Equity |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
Accounts payables and accrued liabilities |
$ 272,284 |
$ 274,907 |
|
Deferred revenue |
79,631 |
- |
|
Current portion of bank loan payable |
7,489 |
6,672 |
|
Deferred capital contributions |
5,188 |
8,356 |
|
Debenture payable |
50,000 |
50,000 |
|
Current portion of license liability |
114,967 |
110,442 |
|
|
529,559 |
450,377 |
|
|
|
|
|
Bank loan payable |
23,072 |
31,901 |
|
Loan payable |
250,726 |
242,109 |
|
Convertible debentures |
789,891 |
- |
|
License liability |
130,492 |
266,046 |
|
|
1,723,740 |
990,433 |
|
|
|
|
|
Shareholders' Equity: |
|
|
|
Share capital |
3,725,812 |
3,712,635 |
|
Warrants |
678,168 |
629,426 |
|
Equity portion of convertible debentures |
95,635 |
- |
|
Contributed surplus |
328,127 |
281,209 |
|
Accumulated deficit |
(3,230,399) |
(1,869,138) |
|
|
1,597,343 |
2,754,132 |
|
|
|
|
|
|
$ 3,321,083 |
$ 3,744,565 |
|
|
|
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended |
|
|
|
|
|
2025 |
2024 |
|
|
|
|
|
|
|
Cash provided by (used in): |
|
|
|
|
|
|
|
|
|
|
|
Operating activities: |
|
|
|
|
|
Net loss |
|
|
$ (1,361,261) |
$ (896,561) |
|
Items not involving cash |
|
|
403,538 |
39,851 |
|
Changes in non‑cash operating working capital |
|
|
7,495 |
(813,030) |
|
Net cash used in operating activities |
|
|
(950,228) |
(1,669,740) |
|
|
|
|
|
|
|
Financing activities: |
|
|
|
|
|
Proceeds from convertible debentures |
|
|
969,500 |
- |
|
Repayment of bank loan payable |
|
|
(7,605) |
(11,925) |
|
Proceeds from issuance of subscription receipts |
|
|
- |
1,700,000 |
|
Issuance costs |
|
|
- |
(172,605) |
|
Interest paid |
|
|
(2,446) |
- |
|
Net cash provided by financing activities |
|
|
959,449 |
1,515,470 |
|
|
|
|
|
|
|
Investing activities: |
|
|
|
|
|
Purchase of property and equipment |
|
|
(26,127) |
(193,236) |
|
Cash obtained from reverse takeover transaction |
|
|
- |
3,299 |
|
Net cash (used in) provided by investing activities |
|
|
(26,127) |
(189,937) |
|
|
|
|
|
|
|
Change in cash |
|
|
(16,907) |
(344,207) |
|
|
|
|
|
|
|
Cash, beginning of period |
|
|
673,249 |
1,505,223 |
|
|
|
|
|
|
|
Cash, end of period |
|
|
$ 656,342 |
$ 1,161,016 |
|
|
|
|
|
|
About
For more information, please visit www.forwardwater.com.
Neither the
Forward-Looking Statements
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws including statements regarding expansion and uptake of the Company's technology and the ability for the Company to achieve its growth strategy and business plan. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, the ability to scale the technology and the adoption of the technology by potential customers.
Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Some of the risks and other factors that could cause results to differ materially from those expressed in the forward-looking statements include, but are not limited to: the impacts from pandemics or other epidemics, general economic conditions in
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information
SOURCE